Health
Common medicines could lead to cancer patients’ deaths – Ballina Shire Advocate
Cancer patients are more likely to die of their disease if they use common antacids bought at the chemist at the same time as immunotherapy treatments.
Cancer patients are more likely to die of their disease if they use common antacids at the same time as immunotherapies a groundbreaking Australian study has found.
Flinders University researchers found bladder cancer patients using antacids called proton pump inhibitors (PPIs) were more likely to have their cancer progress and were less likely to respond to the breakthrough immunotherapy cancer treatment atezolizumab than those not using antacids.
The reason is the antacids change the patient…
-
Business20 hours agoWhy Vault Minerals, Droneshield, Westgold Resources shares are climbing higher today
-
Noosa News15 hours agoRacing Queensland responds to criticism of ‘deadliest’ greyhound track
-
Noosa News23 hours agoDramatic details emerge of moment woman loses arm in attack by lion in Queensland Zoo
-
Noosa News20 hours agoQueensland’s nurses and midwives ramp up industrial action as pay negotiations break down